I am an investor for the long term in CST but I don't dress it up in sexy lingerie and have sizzling dreams about it the way some members of this board do.
I am trying to give this forum what some analysts are currently thinking.
Anyway here goes it again don’t shoot the messenger.
This company is very speculative. It is possible to make large amounts of money, and it is possible to lose it all (or most of it).
One of the biggest problems with startups is that it always takes much longer than expected to bring the products to level of sales and profitability so that the company is sustainable without continual cash injections. In many cases the companies run out of money before that level is reached. Even when it gets to this level, frequently it needs a lot of extra cash to scale up to a more competitive size.
So I think that one of the most important things in this area is to check is how much cash the business has, and how long can it keep running at existing levels before it needs more.
Looking at Cellestis, I note that it has $14 million in cash and has now started to turn a profit. So perhaps this is one of those companies that makes it. Certainly its “story” sounds good -- but they generally do.
On the bright side it can be an enormous amount of fun to have a few bob in companies such as Cellestis. The annual meetings are typically very small and the company usually gathers a group of very supportive investors.
Cheers
CST Price at posting:
$2.01 Sentiment: Buy Disclosure: Held
